1. Home
  2. HAWK vs XNCR Comparison

HAWK vs XNCR Comparison

Compare HAWK & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HawkEye 360 Inc. Common Stock

HAWK

HawkEye 360 Inc. Common Stock

N/A

Current Price

$14.63

Market Cap

2.0B

Sector

Technology

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$24.58

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HAWK
XNCR
Founded
2015
1997
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2026
2013

Fundamental Metrics

Financial Performance
Metric
HAWK
XNCR
Price
$14.63
$24.58
Analyst Decision
Strong Buy
Buy
Analyst Count
10
14
Target Price
★ $32.56
$31.42
AVG Volume (30 Days)
★ 1.2M
1.0M
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.36
EPS
★ N/A
N/A
Revenue
N/A
★ $125,576,000.00
Revenue This Year
$84.87
$14.05
Revenue Next Year
$24.92
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 13.65
52 Week Low
$15.21
$10.38
52 Week High
$25.71
$30.61

Technical Indicators

Market Signals
Indicator
HAWK
XNCR
Relative Strength Index (RSI) 28.61 51.52
Support Level N/A $23.36
Resistance Level $17.42 $30.61
Average True Range (ATR) 0.68 1.03
MACD 0.02 -0.09
Stochastic Oscillator 2.26 55.23

Price Performance

Historical Comparison
HAWK
XNCR

About HAWK HawkEye 360 Inc. Common Stock

Hawkeye 360 Inc operates in the signals intelligence (SIGINT) and defense technology sector. It provides end-to-end signals intelligence solutions integrated into national security systems for the United States and allied customers. Its offerings include radio frequency data and related insights to support defense operations. The company is involved across the value chain, including satellite design and manufacturing, data collection, and data processing and analysis. It generates revenue prominently from fixed price contract arrangements for RF signal mapping products that are used to analyze and track radio waves.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: